Click HERE to download the PDF

“Innovation Initiatives” is a long-term vision that drives Olon’s growth. A strategy of significant investments in processes, capabilities, and state-of-the-art technologies to offer one of the most complete and reliable end-to-end integrated CDMO platforms globally. Olon Group, which in the past five years alone has more than doubled growth in strategic investments, is developing capabilities and expertise that make it the partner of choice for pharmaceutical companies, owing to the support it is able to provide throughout all stages of the development process. This includes for new generation molecules, which are the focus of much of the research and development of the global pharmaceutical market. The general trend has been to steer the development of new therapies towards increasingly selective ...